Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 3 | 312.50 | 257.33 | 287.00 | 458.00 | 0.6266 | 0.1402 | |
| SK-BR-3 | 0 | uM | 3 | 625.00 | 556.96 | 787.00 | 1097.75 | 0.7169 | 0.4236 | |
| SK-BR-3 | 0 | uM | 3 | 625.00 | 556.96 | 937.00 | 1097.75 | 0.8536 | 0.7013 | |
| SK-BR-3 | Methotrexate | 0.031623 | uM | 3 | 625.00 | 556.96 | 810.00 | 1097.75 | 0.7379 | 0.4661 |
| SK-BR-3 | Omipalisib | 1 | uM | 3 | 625.00 | 556.96 | 356.00 | 1097.75 | 0.3243 | -0.3670 |
| SK-BR-3 | Methotrexate | 0.1 | uM | 3 | 625.00 | 556.96 | 850.00 | 1097.75 | 0.7743 | 0.5401 |
| SK-BR-3 | Taxol | 0.031623 | uM | 3 | 625.00 | 556.96 | 409.00 | 1097.75 | 0.3726 | -0.2705 |
| SK-BR-3 | Palbociclib | 10 | uM | 3 | 625.00 | 556.96 | 614.00 | 1097.75 | 0.5593 | 0.1047 |
| SK-BR-3 | Palbociclib | 0.0033113 | uM | 3 | 625.00 | 556.96 | 1159.00 | 1097.75 | 1.0558 | 1.1141 |
| SK-BR-3 | Taxol | 0.01 | uM | 3 | 625.00 | 556.96 | 393.00 | 1097.75 | 0.3580 | -0.2997 |
| SK-BR-3 | Palbociclib | 3.1623 | uM | 3 | 625.00 | 556.96 | 844.00 | 1097.75 | 0.7689 | 0.5290 |
| SK-BR-3 | Methotrexate | 0.01 | uM | 3 | 625.00 | 556.96 | 1199.00 | 1097.75 | 1.0922 | 1.1886 |
| SK-BR-3 | Taxol | 0.00016596 | uM | 3 | 625.00 | 556.96 | 1235.00 | 1097.75 | 1.1250 | 1.2558 |
| SK-BR-3 | Taxol | 0.00033113 | uM | 3 | 625.00 | 556.96 | 1051.00 | 1097.75 | 0.9574 | 0.9130 |
| SK-BR-3 | Palbociclib | 0.1 | uM | 3 | 625.00 | 556.96 | 957.00 | 1097.75 | 0.8718 | 0.7384 |
| SK-BR-3 | Omipalisib | 10 | uM | 3 | 625.00 | 556.96 | 409.00 | 1097.75 | 0.3726 | -0.2705 |
| SK-BR-3 | 0 | uM | 3 | 625.00 | 556.96 | 1125.00 | 1097.75 | 1.0248 | 1.0507 | |
| SK-BR-3 | Palbociclib | 1 | uM | 3 | 625.00 | 556.96 | 799.00 | 1097.75 | 0.7279 | 0.4458 |
| SK-BR-3 | Methotrexate | 3.1623 | uM | 3 | 625.00 | 556.96 | 988.00 | 1097.75 | 0.9000 | 0.7960 |
| SK-BR-3 | Omipalisib | 0.0033113 | uM | 3 | 625.00 | 556.96 | 860.00 | 1097.75 | 0.7834 | 0.5586 |
| SK-BR-3 | Omipalisib | 0.0016596 | uM | 3 | 625.00 | 556.96 | 863.00 | 1097.75 | 0.7862 | 0.5642 |
| SK-BR-3 | Palbociclib | 0.31623 | uM | 3 | 625.00 | 556.96 | 774.00 | 1097.75 | 0.7051 | 0.3996 |
| SK-BR-3 | Taxol | 0.1 | uM | 3 | 625.00 | 556.96 | 428.00 | 1097.75 | 0.3899 | -0.2359 |
| SK-BR-3 | 0 | uM | 3 | 625.00 | 556.96 | 1180.00 | 1097.75 | 1.0749 | 1.1532 | |
| SK-BR-3 | 0 | uM | 3 | 625.00 | 556.96 | 714.00 | 1097.75 | 0.6504 | 0.2888 |